Expanding living donor liver transplantation
Chung‐Mau Lo – 30 August 2016
Serum markers for hepatocellular carcinoma
Paul Clark – 29 August 2016
Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile
Manon Allaire, Jean Charles Nault – 29 August 2016
Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Effective and justified?
Nataliya Razumilava, Gregory J. Gores – 29 August 2016
Velpatasvir and sofosbuvir: How will we use a new drug when the old agents work well?
Steven L. Flamm – 29 August 2016
Biomarkers of immunosuppression
Tiong Yeng Lim, Michael Heneghan – 29 August 2016
Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Effective and justified?
Nataliya Razumilava, Gregory J. Gores – 29 August 2016
Statins and metformin for chemoprevention of hepatocellular carcinoma
Jonggi Choi, Lewis R. Roberts – 29 August 2016
Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile
Manon Allaire, Jean Charles Nault – 29 August 2016
Statins and metformin for chemoprevention of hepatocellular carcinoma
Jonggi Choi, Lewis R. Roberts – 29 August 2016